Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer

被引:31
|
作者
de Geus-Oei, LF [1 ]
Oei, HY [1 ]
Hennemann, G [1 ]
Krenning, EP [1 ]
机构
[1] Univ Rotterdam Hosp, Dept Nucl Med, Dijkzigt, Netherlands
关键词
differentiated thyroid carcinoma; follow-up; iodine-123; iodine-131; thyroglobulin;
D O I
10.1007/s00259-002-0781-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Primary treatment of differentiated thyroid carcinoma consists of total thyroidectomy followed by ablation of thyroid tissue remnants and possible metastases by means of radioactive iodine. After complete destruction of remnants, metastases or recurrence can be detected by measurement of the serum thyroglobulin level as well as by radionuclide methods. Here we report on the sensitivity of diagnostic I-123 scintigraphy and serum thyroglobulin measurement for tumour detection in patients with proven recurrence or metastases. Fifty-five patients who received their first high activity (1,850-5,550 MBq) of I-123 therapy after total thyroidectomy and I-131 ablation were included in the study. The thyroglobulin level was measured both during TSH-suppressive L-thyroxine therapy (Tg-on) and 4-6 weeks after L-thyroxine withdrawal (Tg-off, TSH>0 mU/l). Prior to treatment, whole-body scanning (WBS) was performed 24 h after the administration of 111-370 MBq I-123. The therapeutic activity of 1,850-5,550 MBq I-131 was administered within 24 h after diagnostic scanning. The mean interval between I-131 therapy and post-therapeutic WBS was 8.6 days (range 3-15 days). The sensitivity of WBS, Tg-on and T-off was 75%, 82% and 98%, respectively. The overall sensitivity of the combination of Tg-on with WBS and of Tg-off with WBS was 95% and 100%, respectively. In 12 out of 51 cases either Tg-off or Tg-on or both T-on and To-off levels were elevated while I-123-WBS was negative. More lesions were visible on the post-therapeutic I-131 scan than on the corresponding diagnostic I-123 scan (n=13). Tg values increased significantly (P<0.0001) after thyroid hormone withdrawal. Early treatment of distant metastases or tumour remnants of differentiated thyroid carcinoma is favoured and I-131 treatment should also be considered in patients with a negative WBS but positive serum Tg level. The finding of a positive Tg-off level, which is clearly above the corresponding Tg-on value, is sufficient to make this decision. Additional diagnostic I-123 WBS will not improve sensitivity.
引用
收藏
页码:768 / 774
页数:7
相关论文
共 50 条
  • [31] Utility of 123I scintigraphy in the pretherapeutic staging of Differentiated Thyroid Cancer
    Mestre, A.
    Negre, M.
    Obiols, G.
    Mesa, J.
    Porta, F.
    Castell-Conesa, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S304 - S304
  • [32] METASTASIZING DIFFERENTIATED THYROID-CARCINOMA - DIAGNOSTIC SENSITIVITY OF THYROGLOBULIN-RIA IN COMPARISON TO WHOLE-BODY SCINTIGRAPHY WITH - I-131
    REINERS, C
    REIMANN, J
    SCHAFFER, R
    BAUM, K
    BECKER, W
    EILLES, C
    GERHARDS, W
    SCHICK, F
    SPIEGEL, W
    WIEDEMANN, W
    BORNER, W
    FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NUKLEARMEDIZIN, 1984, 141 (03): : 306 - 313
  • [33] CAN I-131 WHOLE-BODY SCAN BE REPLACED BY THYROGLOBULIN MEASUREMENT IN THE POSTSURGICAL FOLLOW-UP OF DIFFERENTIATED THYROID-CARCINOMA
    RONGA, G
    FIORENTINO, A
    PASERIO, E
    SIGNORE, A
    TODINO, V
    TUMMARELLO, MA
    FILESI, M
    BASCHIERI, I
    JOURNAL OF NUCLEAR MEDICINE, 1990, 31 (11) : 1766 - 1771
  • [35] Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
    van Tol, KM
    Jager, PL
    de Vries, EGE
    Piers, DA
    Boezen, HM
    Sluiter, WJ
    Dullaart, RPF
    Links, TP
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (06) : 589 - 596
  • [36] The Correlation of Radioiodine Whole Body Scan and Stimulated Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
    Vlajkovic, M.
    Matovic, M.
    Rajic, M.
    Ilic, S.
    Stevic, M.
    Karanikolic, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S351 - S351
  • [37] Post-Surgical 131I Ablation in Patients with Papillary Thyroid Cancer: The Role of Diagnostic 123I Whole Body Scan
    Iagaru, A.
    Mosci, C.
    Akatsu, H.
    Basina, M.
    Dosiou, C.
    McDougall, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S235 - S235
  • [38] SERUM THYROGLOBULIN CONCENTRATIONS AND I-131 WHOLE-BODY SCANS IN THE DIAGNOSIS OF METASTASES FROM DIFFERENTIATED THYROID-CARCINOMA (AFTER THYROIDECTOMY)
    PACINI, F
    PINCHERA, A
    GIANI, C
    GRASSO, L
    BASCHIERI, L
    CLINICAL ENDOCRINOLOGY, 1980, 13 (01) : 107 - 110
  • [39] Pitfalls of Iodine-131 whole-body scan mimicking metastases in differentiated thyroid carcinoma: A case series
    Shaik, Rishma
    Hemalatha, Dhamarcherla S.
    Rallapeta, Ramya Priya
    Sireesha, Polisetty
    Gavini, Surya Teja
    Kalawat, Tekchand
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (01): : 47 - 51
  • [40] Stratification of recurrent differentiated thyroid cancer with elevated thyroglobulin and negative I-131 whole body scan by restaging 18F FDG PET/CT
    Okuyucu, K.
    Ince, S.
    Alagoz, E.
    Emer, O.
    San, H.
    Balkan, E.
    Ayan, A.
    Gunalp, B.
    Karacalioglu, A. O.
    Arslan, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S649 - S650